Patricia M. Drake
Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc.Ms. Patricia M. Drake is Chief Commercial Officer-Innoviva Specialty Therapeutics, Inc. at Innoviva, Inc. from July 2024. She is to play a key role in shaping the company's commercial strategy and driving growth of the company's commercial portfolio of infectious disease and critical care products, which include XACDURO (sulbactam-durlobactam), XERAVA (eravacycline) and GIAPREZA (angiotensin II). Ms. Drake is a highly accomplished life science leader who has bought unique experience and achievements to Innoviva Specialty Therapeutics. Her strong leadership background, encompassing strategy, marketing, market access, sales and commercial operations, is a testament to her capabilities. During her tenure at Merck, she successfully led commercial organizations across diverse global markets and product portfolios, which included antiviral, oncology, antifungal and antibiotic products and multiple global business units spanning North and South America and the Nordics. Before joining Innoviva Specialty Therapeutics. Ms. Drake had been the Senior VP & Chief Commercial Officer at Trevena, Inc. since November 2021 until May 2024. She had been Chief Commercial Officer at Sesen Bio, Inc. since June 1, 2021 until September 2021. Prior to joining Sesen Bio, Ms. Drake spent her career at Merck & Co. Inc in various leadership roles. During her tenure, Ms. Drake progressed through numerous commercial roles of increasing responsibility in marketing, sales, strategy and operations, also as Managing Director and CEO of Merck, Sharp & Dohme (MSD) Finland from January 2019 to May 2021. Ms. Drake led the Global Human Health Strategy realization and orchestrated sales force deployments as Vice President of Sales in Canada. She enjoyed commercial success in Latin America managing Merck’s Diversified Brands, including Bacillus Calmette Gurin (BCG) in 2011 and 2012. Ms. Drake is well-known as an inspiring and inclusive leader who is dedicated to the development of her teams and solely focused on organizational success for the benefit of patients. Ms. Drake received her bachelor’s degree from Wichita State University and is graduate of the Harvard Business School Executive Leadership Program.
Positions
- Company NameInnoviva, Inc.Stock CodeINVAPositionChief Commercial Officer-Innoviva Specialty Therapeutics, Inc.
